e-Therapeutics (LSE:ETX) Net Margin % : -3,496.25% (As of Jul. 2023)

e-Therapeutics Net Margin % Chart

e-Therapeutics Annual Data
	Trend	Jan14	Jan15	Jan16	Jan17	Jan18	Jan19	Jan20	Jan21	Jan22	Jan23
Net Margin %		Get a 7-Day Free Trial					-9,088.64	-514.69	-1,162.15	-1,691.19	-1,741.89

e-Therapeutics Semi-Annual Data
	Jan14	Jul14	Jan15	Jul15	Jan16	Jul16	Jan17	Jul17	Jan18	Jul18	Jan19	Jul19	Jan20	Jul20	Jan21	Jul21	Jan22	Jul22	Jan23	Jul23
Net Margin %	Get a 7-Day Free Trial															-584.49	-	-1,292.20	-2,478.89	-3,496.25

Competitive Comparison of e-Therapeutics's Net Margin %

For the Biotechnology subindustry, e-Therapeutics's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

e-Therapeutics's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, e-Therapeutics's Net Margin % distribution charts can be found below:

* The bar in red indicates where e-Therapeutics's Net Margin % falls into.

e-Therapeutics Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

e-Therapeutics's Net Margin for the fiscal year that ended in Jan. 2023 is calculated as

e-Therapeutics's Net Margin for the quarter that ended in Jul. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

e-Therapeutics  (LSE:ETX) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

e-Therapeutics Net Margin % Related Terms

Thank you for viewing the detailed overview of e-Therapeutics's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

e-Therapeutics (LSE:ETX) Business Description